DJIA 17,031.14 43.63 0.26%
NASDAQ 4,518.90 -48.70 -1.07%
S&P 500 1,984.13 -1.41 -0.07%
market minute promo

51.38 -0.70 (-1.34%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

TEVA $51.38 -1.34%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $51.83
Previous Close $52.08
Daily Range $51.27 - $52.05
52-Week Range $36.26 - $55.70
Market Cap $43.9B
P/E Ratio 34.95
Dividend (Yield) $1.20 (2.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,836,122
Average Daily Volume 3,584,907
Current FY EPS $4.93





Teva Pharmaceutical Industries (TEVA) Description

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website:

News & Commentary

3 Reasons Actavis plc Stock Could Fall

Shares of specialty drugmaker Actavis have been ripping higher over the past two years. Here are three reasons why this trend could be coming to an end.

COPD Occurs Most Often in These 5 States

COPD affects more than 6% of the U.S. population and costs $50 billion in direct and indirect costs annually, but these five states have the highest occurrence rate in the country.

Teva Pharmaceutical Is Poised To Grow

Strong Portfolio Will Drive Growth For Mylan

3 Stocks Underperforming Today In The Health Care Sector

Teva Pharmaceuticals New Drug Aims to Reduce Asthma Attacks

Teva Pharmaceutical's reslizumab may some day offer a new treatment option for moderate and severe asthma patients.

Is It Time to Buy Hospira, Inc.'s Stock?

Hospira has had a great run over the past 12 months. Is it time to buy or sell this high-flying stock?

Is It Time to Buy Actavis plc Stock?

Shares of specialty drugmaker Actavis have been hitting all-time highs lately. With an acquisition-fueled revenue bonanza taking place, is it time to buy shares of this red-hot biopharma?

The 1 George Soros Quote Every Investor Should Read Right Now

Is an epic bear market brewing? George Soros has some sage advice that investors should keep in mind.

The Gurus' Favorite Asian Stocks

See More TEVA News...

TEVA's Top Competitors

TEVA $51.38 (-1.34%)
Current stock: TEVA
JNJ $104.72 (0.13%)
Current stock: JNJ
PFE $29.92 (1.66%)
Current stock: PFE
NVS $94.18 (0.45%)
Current stock: NVS